The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.50%)
Open: 41.50
High: 41.50
Low: 41.50
Prev. Close: 41.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ALUSID Wins Prestigious IChemE Award

4 Nov 2016 11:00

RNS Number : 3734O
Frontier IP Group plc
04 November 2016
 

 

 

 

AIM: FIPP

RNS Reach

4 November 2016

 

Frontier IP Group Plc ("Frontier IP")

 

Portfolio News - ALUSID Wins Prestigious Institution of Chemical Engineers (IChemE) Award

 

Frontier IP, which specialises in the commercialisation of intellectual property, is pleased to announce that its portfolio company Alusid Limited ("ALUSID") has been awarded this year's IChemE Global Award 2016 for Best Business Start-Up against a shortlist of international nominees, which included businesses from the UK, USA and New Zealand.

The full text of the announcement made by ALUSID is set out below.

ALUSID is delighted to announce that it has won this year's IChemE Global Award 2016 for Best Business Start-Up. The IChemE awards celebrate excellence, innovation and achievement in the chemical, biochemical and process industries.

ALUSID is based in Preston, Lancashire, where it manufactures SilicaStone® - an eco-architectural material made from 100% recycled glass and vitrified ceramic that would otherwise end up in landfill. Its unique, patent pending, process allows for materials to be created without the use of resin, cement or other binders, making it fire and heat resistant as well as making it recyclable at the end of its life.

SilicaStone® was designed as a uniquely adaptable alternative to natural stone products for use as feature walls for interiors and exterior cladding or as solid surfaces. It can be colored and finished in a variety of different shapes and textures all of which are UV stable and durable.

ALUSID is currently working on the design of an automated production plant with a major Italian tile equipment manufacturer in preparation for considerably upscaling production.

Dr Alasdair Bremner, Operations Manager at Alusid, said: "To be recognised in such a strong field for this prestigious award is fantastic. For our work to be recognised for its innovation is testament to the dedication, enthusiasm and commitment of our team in creating a new benchmark for sustainability in construction and architecture."

 

Neil Crabb, Director, Alusid said "It is extremely satisfying to have secured this engineering award for a product which is manufactured from recycled materials, in a low environmental impact manufacturing process that produces zero waste, at a time when ethical manufacturing and sourcing is increasingly important for large corporations and public contracts."

 

Notes

ALUSID - a university spinoff company - was born from a research project led by Professor David Binns and Dr Alasdair Bremner, at the University of Central Lancashire. The company aims to be a leader in the supply of premium engineered sustainable architectural materials and remains at the forefront of this growing sector through continuous research and development.

 

Website: www.alusid.co.uk

High resolution Images are available for download from our website http://www.alusid.co.uk/press-media/

The Institution of Chemical Engineers (IChemE) is the global professional membership organisation for chemical engineering professionals and anyone involved with the process industries, including the emerging bioprocess sector. It has over 44,000 members in over 120 countries. The IChemE awards were held at The Palace Hotel Manchester on Thursday the 3rd of November 2016.

 

ENDS

 

 

Enquiries

 

Frontier IP Group Plc

T: 0131 240 1251

Neil Crabb, Chief Executive

Company website: www.frontierip.co.uk

 

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

T: 020 7894 7000

David Foreman, Catherine Leftley, Corporate Finance

David Banks, Sales

Peterhouse Corporate Finance Limited

(Joint Broker)

T: 020 7469 0935

Lucy Williams

Kreab

T: 020 7074 1800

Robert Speed, Matthew Jervois

 

 

Notes to Editor:

 

About Frontier IP Group plc

www.frontierip.co.uk 

Frontier IP specialises in assisting institutions and companies in the commercialisation and exploitation of their intellectual property. It establishes formal and informal relationships with sources of exploitable IP, principally universities. Its core business is building and growing a portfolio of equity stakes in spin-out companies by taking an active involvement in the commercialisation and funding of these businesses.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFSEFSLFMSEIF
Date   Source Headline
15th Nov 201812:37 pmRNSGrant of Options
15th Nov 201810:05 amRNSExscientia acquires Kinetic Discovery
15th Nov 20189:30 amRNSPlacing to raise £2.49 million
15th Nov 20189:25 amRNSFinal Results
30th Oct 20187:00 amRNSSecond Portuguese spin out: Des Solutio
19th Oct 20187:00 amRNSMolendotech signs collaboration agreement with G's
5th Oct 20187:00 amRNSDIT hails Frontier IP's Portuguese success
27th Sep 20187:00 amRNSChange of Adviser
26th Sep 20185:12 pmRNSDirector Declaration
24th Sep 20182:30 pmRNSHolding(s) in Company
20th Sep 20187:00 amRNSAmprologix to develop new antibiotics with Ingenza
18th Sep 20181:56 pmRNSAlusid raises £1.34m to scale up manufacturing
17th Sep 20187:00 amRNSAB Sugar Head of Innovation joins Frontier IP
30th Aug 201812:39 pmRNSHolding(s) in Company
15th Aug 20187:00 amRNSTVG awarded £50,000 anti-bacterial vaccine grant
7th Aug 20187:00 amRNSPortfolio news - first Portuguese spin out
6th Aug 20187:00 amRNSFieldwork Robotics agreement with Hall Hunter
2nd Aug 20187:00 amRNSFrontier IP partners with UK DIT in Portugal
16th Jul 20187:00 amRNSTarsis Collaboration with Crop-Protection Company
11th Jul 20187:00 amRNSInnovate UK grant for Pulsiv Solar
19th Jun 20187:00 amRNSCambridge Material Testing Solutions
15th May 20187:00 amRNSPalintest launches Molendotech bathing water test
18th Apr 20184:09 pmRNSHolding(s) in Company
9th Apr 20188:25 amRNSIncreased Equity Holding in Fieldwork Robotics
27th Mar 20187:00 amRNSHALF-YEAR RESULTS, 6 MONTHS TO 31 DECEMBER 2017
26th Mar 20187:00 amRNSTeam Expansion and London Office
19th Feb 20187:00 amRNSPortfolio News - Molendotech Secures First Funding
29th Jan 20187:00 amRNSCapital Markets Day
29th Jan 20187:00 amRNSPortfolio News - Molendotech Collaboration
18th Dec 20177:00 amRNSCapital Markets Day
7th Dec 201711:50 amRNSResult of AGM
8th Nov 20177:00 amRNSPosting of Annual Report and Notice of AGM
30th Oct 20175:15 pmRNSHolding(s) in Company
30th Oct 201712:00 pmRNSPortfolio News PulsiV Granted Two US Patents
24th Oct 20177:00 amRNSFinal Results
9th Oct 20177:00 amRNSExscientia Wins Emerging Biotech Company Award
28th Sep 20177:00 amRNSExscientia announces investment from Evotec
25th Sep 20171:12 pmRNSHolding(s) in Company
20th Sep 20177:00 amRNSAlusid extends range at London Design Festival
7th Sep 20177:00 amRNSCSI launches novel sensor system at IFA Berlin
8th Aug 20177:00 amRNSNew Portfolio Company - The Vaccine Group
28th Jul 20173:26 pmRNSHolding(s) in Company
20th Jul 20177:00 amRNSPortfolio News- Nandi Proteins Limited Fundraising
11th Jul 20174:38 pmRNSHolding(s) in Company
5th Jul 20177:00 amRNSNew Portfolio Company - MolEndoTech
3rd Jul 20177:00 amRNSExscientia announces major GSK collaboration
11th May 20177:00 amRNSGrant of Options
9th May 201712:05 pmRNSRoyal Society of Chemistry Nominations
9th May 201711:25 amRNSExscientia announces major Sanofi collaboration
30th Mar 20177:00 amRNSHalf-Year Results for the 6 Months to 31 Dec 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.